XML 72 R4.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 12 Months Ended
Sep. 27, 2019
Jun. 28, 2019
Mar. 29, 2019
Dec. 28, 2018
Sep. 28, 2018
Jun. 29, 2018
Mar. 30, 2018
Dec. 29, 2017
Sep. 27, 2019
Sep. 28, 2018
Sep. 29, 2017
Income Statement [Abstract]                      
Revenue $ 3,951,244 $ 4,010,761 $ 3,999,987 $ 4,265,349 $ 3,913,598 $ 3,971,606 $ 3,939,311 $ 3,965,118 $ 16,227,341 $ 15,789,633 $ 14,604,412
Costs and Expenses:                      
Cost of services provided                 14,532,662 13,997,911 12,995,403
Depreciation and amortization                 592,573 596,182 508,212
Selling and general corporate expenses                 367,256 377,129 299,170
Gain on sale of Healthcare Technologies                 (156,309) 0 0
Cost of services provided 3,503,280 3,594,978 3,639,959 3,794,445 3,386,380 3,526,293 3,563,009 3,522,230 15,336,182 14,971,222 13,802,785
Operating income                 891,159 818,411 801,627
Interest and Other Financing Costs, net                 334,987 346,535 280,985
Income Before Income Taxes                 556,172 471,876 520,642
Provision (Benefit) for Income Taxes                 107,706 (96,564) 146,455
Net income (loss)                 448,466 568,440 374,187
Less: Net income (loss) attributable to noncontrolling interest                 (83) 555 264
Net income attributable to Aramark stockholders $ 85,557 $ 82,955 $ 29,353 $ 250,682 $ 175,455 $ 72,577 $ 27,569 $ 292,284 $ 448,549 $ 567,885 $ 373,923
Earnings per share attributable to Aramark stockholders:                      
Basic (in dollars per share)                 $ 1.82 $ 2.31 $ 1.53
Diluted (in dollars per share)                 $ 1.78 $ 2.24 $ 1.49
Weighted Average Shares Outstanding:                      
Basic (in shares)                 246,854 245,771 244,453
Diluted (in shares)                 252,010 253,352 251,557